Telisotuzumab Vedotin
About
Therapy type: Targeted therapy
Therapy strategy: MET inhibition
Mappings
NCI Thesaurus: Telisotuzumab Vedotin (ncit:C118571)
RxNorm: telisotuzumab vedotin (rxcui:2721996, omop:37354008)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| FDA (1) | c-Met >= 50% | Lung Non-Squamous Non-Small Cell Carcinoma | Telisotuzumab Vedotin |